Emily Kramer-Golinkoff, a cystic fibrosis patient with a rare mutation, highlights the struggles of those left behind as gene therapies show promise for others. Her journey underscores the need for equitable treatments in rare genetic conditions.
A recent study reveals that CT scans may be responsible for approximately 5% of all cancer diagnoses in the U.S., ranking alongside major cancer contributors like smoking and obesity. Experts urge caution in their use and the need for standardized radiation doses to mitigate risks.
A new study reveals that combinations of common food additives may increase the risk of Type 2 diabetes. Researchers analyzed data from over 108,000 adults, highlighting specific additive mixtures linked to health risks.
A groundbreaking study from Wales reveals that receiving the shingles vaccine may reduce the risk of developing dementia by 20%. This unexpected finding could change how we approach dementia prevention and treatment.
As Trump faces backlash for his extreme tariff policies, he claims he's not tanking the stock market intentionally. With ominous predictions of a 'Black Monday', experts warn of dire consequences ahead.
A team of scientists at Johns Hopkins Medicine has unveiled how glutamate activates brain receptors using advanced cryo-EM imaging, paving the way for novel treatments for epilepsy and other neurological conditions.
In a surprising turn of events, family doctors like Dr. Leila Myrick are encountering measles cases for the first time as an outbreak infects hundreds in Texas. With vaccination rates dropping, experts are alarmed by the resurgence of this once-eliminated virus.
In a surprising turn, Indian drugmakers' shares jumped 5% following the U.S. exempting pharmaceuticals from new tariffs. This decision could significantly boost India's pharma exports, which reached $9 billion last year.
In a shocking act, Myanmar's military fired on a Red Cross convoy delivering crucial aid to earthquake survivors, illustrating the perils faced by humanitarian groups amid ongoing conflict. Despite declared cease-fires, military operations persist.
A new blood test developed by experts at Washington University and Lund University could change the way Alzheimer’s is diagnosed and treated, identifying disease progression and guiding personalized care.
